Final Report of EORTC 26951 and RTOG 9402 for Anaplastic Oligodendroglial Tumors

Affiliations

¹ Binghao Zhao, MD, PhD, Jiaming Wu, MD, Huanzhang Li, MD, and Wenbin Ma, MD, Departments of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Comment

Binghao Zhao et al. J Clin Oncol. 2023.

. 2023 Feb 1;41(4):933-934.

doi: 10.1200/JCO.22.01492. Epub 2022 Oct 3.

¹ Binghao Zhao, MD, PhD, Jiaming Wu, MD, Huanzhang Li, MD, and Wenbin Ma, MD, Departments of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

No abstract available

Comment in

Reply to B. Zhao et al.
Polley MC, Gorlia T, Lassman AB, van den Bent MJ. Polley MC, et al. J Clin Oncol. 2023 Feb 1;41(4):934-935. doi: 10.1200/JCO.22.01874. Epub 2022 Oct 3. J Clin Oncol. 2023. PMID: 36191279 No abstract available.

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
Lassman AB, Hoang-Xuan K, Polley MC, Brandes AA, Cairncross JG, Kros JM, Ashby LS, Taphoorn MJB, Souhami L, Dinjens WNM, Laack NN, Kouwenhoven MCM, Fink KL, French PJ, Macdonald DR, Lacombe D, Won M, Gorlia T, Mehta MP, van den Bent MJ. Lassman AB, et al. J Clin Oncol. 2022 Aug 10;40(23):2539-2545. doi: 10.1200/JCO.21.02543. Epub 2022 Jun 22. J Clin Oncol. 2022. PMID: 35731991 Free PMC article.